Table 1 Baseline characteristics of study participants.
Variable | Non-Diabetes (n = 206) | Diabetes (n = 206) | P value |
|---|---|---|---|
Gender, n (%) | 0.921 | ||
Female | 113 (54.85) | 113 (54.85) | |
Male | 93 (45.15) | 93 (45.15) | |
Age (year) | 61.54 ± 11.93 | 61.7 ± 11.51 | 0.890 |
< 50 | 34 (16.51) | 34 (16.51) | |
50–59 | 64 (31.07) | 64 (31.07) | |
60–69 | 53 (25.73) | 53 (25.73) | |
70–79 | 39 (18.93) | 39 (18.93) | |
≥ 80 | 16 (7.77) | 16 (7.77) | |
BMI (Kg/m2) | 28.73 ± 5.06 | 29.00 ± 4.9 | 0.582 |
< 18.5 | 1 (0.49) | 1 (0.49) | |
18.5–24.9 | 43 (20.87) | 42 (20.39) | |
25.0–29.9 | 83 (40.29) | 82 (39.8) | |
≥ 30 | 79 (38.35) | 81 (39.32) | |
WC/HC (cm) | 0.94 ± 0.08 | 0.95 ± 0.13 | 0.380 |
Blood pressure (mmHg) | |||
Systolic | 138.09 ± 21.88 | 140.88 ± 22.39 | 0.202 |
Diastolic | 82.02 ± 12.12 | 82.33 ± 13.08 | 0.803 |
FPG (mg/dL) | 95.1 ± 12.0 | 153.27 ± 62.74 | < 0.001 |
HbA1c (%) | 5.58 ± 0.4 | 7.68 ± 1.75 | < 0.001 |
HDL-C (mg/dL) | 42.27 ± 11.83 | 38.43 ± 11.42 | 0.001 |
Non-HDL Cholesterol (mg/dL) | 100.37 ± 25.44 | 92.32 ± 34.32 | 0.008 |
Cholesterol (mg/dL) | 167.92 ± 31.84 | 163.95 ± 43.58 | 0.294 |
Triglycerides (mg/dL) | 128.98 ± 67.80 | 170.69 ± 157.88 | < 0.001 |
Hyperlipidemia medication | 16 (7.77) | 53 (25.73) | < 0.001 |
